Shuai Wang

Dr. Shuai Wang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2023 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
MWMing Wei
Ming Wei
PWPeng Wang
Peng Wang
TLTianmeng Li
Tianmeng Li
QWQiangyi Wang
Qiangyi Wang
MSMingze Su
Mingze Su
SWShuai Wang
Shuai Wang
Introduction: Enterococcus faecium is a leading cause of hospital-acquired infections, which has become a serious public health concern. The increasing incidence of vancomycin-resistant E. faecium (VRE-fm) raises an urgent need to find new antimicrobial agents as a complement to traditional antibiotics. The study aimed to evaluate the antimicrobial and antibiofilm activity of essential fatty acids (EFAs) against VRE-fm, and further explore the molecular mechanism of the antibiofilm activity of EFAs.Method: The microdilution broth method was used for antimicrobial susceptibility testing with traditional antibiotics and EFAs, including α-linolenic acid (ALA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), linoleic acid (LOA), γ-linolenic acid (GLA), and arachidonic acid (AA). The effect of EFAs on cell morphology of VRE-fm was investigated by scanning electron microscopy. The crystal violet method was used to evaluate the antibiofilm activities of EFAs against VRE-fm. Furthermore, the expression of biofilm-related genes (acm, atlA, esp, and sagA) of VRE-fm isolates under the action of GLA was analyzed using quantitative reverse transcription PCR (qRT-PCR) assay.Results: VRE-fm isolates were highly resistant to most traditional antibiotics, only highly susceptible to quinupristin-dalfopristin (90.0%), tigecycline (100%), and linezolid (100%). EPA, DHA, and GLA exhibited excellent antimicrobial activity. The MIC50/90 of EPA, DHA, and GLA were 0.5/1, 0.25/0.5, and 0.5/1 mM, respectively. SEM imaging showed that strain V27 adsorbed a large number of DHA molecules. Furthermore, all EFAs exhibited excellent inhibition and eradication activities against VRE-fm biofilms. The biofilm inhibition rates of EFAs ranged from 45.3% to 58.0%, and eradication rates ranged from 54.1% to 63.4%, against 6 VRE-fm isolates with moderate biofilm formation ability. GLA exhibited remarkable antibiofilm activity against VRE-fm isolates. The qRT-PCR analysis showed that GLA could significantly down-regulate the expression of the atlA gene (P < 0.01) of VRE-fm.Conclusion: DHA showed the strongest antibacterial activity, while GLA showed the strongest antibiofilm effect among the EFAs with antibacterial activity. Our novel findings indicate that the antibiofilm activity of GLA may be through down-regulating the atlA gene expression in VRE-fm. Therefore, DHA and GLA had the potential to be developed as therapeutic agents to treat infections related to multiple antimicrobial-resistant E. faecium.

4 November 2025 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
PWPeng Wang
Peng Wang
YPYaqin Peng
Yaqin Peng
JLJun Liu
Jun Liu
TLTianmeng Li
Tianmeng Li
DZDan Zhang
Dan Zhang
SWShuai Wang
Shuai Wang
Pulmonary mucormycosis (PM), a life-threatening infection caused by Mucorales, exhibits high mortality. Comprehensive data integrating clinical profiling, antifungal susceptibility, and biofilm formation ability are limited. This retrospective study characterized 26 adult PM patients at a Beijing tertiary-care hospital. Data on demographics, underlying diseases, co-infections, and outcomes were collected. Clinical Mucorales isolates underwent molecular identification via 18 S rRNA gene sequencing and phylogenetic analysis. In vitro susceptibility against nine antifungals (amphotericin B, fluconazole, voriconazole, itraconazole, posaconazole, caspofungin, micafungin, anidulafungin, 5-flucytosine) was determined using Sensititre YeastOne YO10 panels. Biofilm biomass was assessed (24 h, 48 h, 72 h) via the crystal violet staining assay. Patients were predominantly older males (median age 66 years, 65.4% male) with high comorbidity burden (92.3%). All-cause in-hospital mortality was 38.5%. Strikingly, 80.8% had co-infections. Temporal analysis revealed that viral (77.8%) and fungal (62.5%) co-infections often preceded the detection of Mucorales. Molecular identification confirmed Rhizopus spp. (54%) predominated, followed by Rhizomucor spp. (19%), Mucor spp. (19%), and Lichtheimia spp. (8%). Antifungal testing showed amphotericin B possessed the most consistent activity (MIC50/MIC90: 1/2 µg/mL). Posaconazole was the most potent azole (MIC50/MIC90: 0.25/1 µg/mL), but profound genus-level heterogeneity was observed. Biofilm assessment at the 48-h peak revealed biofilm formation in 84.6% (22/26) of isolates. This study highlights the high prevalence of antecedent viral/fungal co-infections preceding Mucorales detection and significant mortality, despite in vitro susceptibility to amphotericin B/posaconazol. In addition, most of the strains demonstrated biofilm formation ability, with evident genus-level heterogeneity. These findings emphasize the imperative of species-level identification and consideration of genus-specific traits to guide effective management of this life-threatening infection.

24 April 2025 in Microbial Pathogenesis
Verified
Journal Article
Closed access
TLTianmeng Li
Tianmeng Li
HSHong Shen
Hong Shen
PWPeng Wang
Peng Wang
YWYu Wang
Yu Wang
JLJun Liu
Jun Liu
MWMing Wei
Ming Wei

29 November 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
BHBingfeng Han
Bingfeng Han
WLWu Liu
Wu Liu
JDJuan Du
Juan Du
HLHanyu Liu
Hanyu Liu
TZTianshuo Zhao
Tianshuo Zhao
FCFuqiang Cui
Fuqiang Cui
Background: In initial studies, the immunogenicity and safety of hepatitis B vaccines in patients with diabetes has been assessed in China. Methods: In six township health centers in Gansu Province, 232 diabetic patients and 77 healthy people were allocated to receive two 3-dose hepatitis B vaccines (Group D20SC 0-1-6; Group D20CHO 0-1-6; Group ND20SC 0-1-6). Participants were followed up at 12 months after being fully vaccinated. One dose of the vaccine was randomly administered to non-responders. Chi-square test was used to compare the differences in response rate between two groups. Results: The anti-HBs response rates of three groups decreased from 84.1%, 89.1% and 88.3% at one month to 64.6%, 79.8% and 71.4% at twelve months. There was no statistical difference in the immune response rates between Group D20SC 0-1-6 and Group ND20SC 0-1-6; however, that of Group D20CHO 0-1-6 was higher than that of Group D20SC 0-1-6. After revaccination, the geometric mean concentrations were 491.7 mIU/mL and 29.7 mIU/mL after using vaccines containing 60 μg and 20 μg HBsAg. Conclusions: At 12 months, immune response in diabetic patients were not significantly different from that in healthy people. Revaccination with one dose of hepatitis B vaccine containing 60 μg HBsAg for non-responders was more satisfactory.

7 August 2026 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
MWMing Wei
Ming Wei
SXShiwang Xie
Shiwang Xie
PWPeng Wang
Peng Wang
TLTianmeng Li
Tianmeng Li
JLJun Liu
Jun Liu
SWShuai Wang
Shuai Wang
Background: Conventional antibiotics against slow-growing, mycolic acid-rich Nocardia often require prolonged therapy and are associated with high relapse rates. Membrane-targeting essential fatty acids may circumvent growth-dependent resistance. Methods: Five essential fatty acids were screened against 82 clinical Nocardia isolates by broth microdilution. Docosahexaenoic acid (DHA) was further assessed for bactericidal kinetics, membrane integrity by propidium iodide staining and scanning electron microscopy, transcriptomic profiling, and combined activity with amikacin and tobramycin. Results: α-Linolenic acid, γ-linolenic acid, eicosapentaenoic acid and DHA exhibited comparable activity (MIC 50/ MIC 90 : 31.25/62.50 μM), corresponding to mass concentration ranges of 8.7 to 10.3 μg/mL for MIC 50 and 17.4 to 20.6 μg/mL for MIC 90 . However, arachidonic acid was markedly less active. DHA rapidly disrupted the Nocardia cell envelope, causing propidium iodide influx and ultrastructural damage, and achieved concentration-dependent bactericidal killing within 1 h, a feat not observed with imipenem. Transcriptomic analysis of the surviving subpopulation revealed downregulation of the proton-pumping Nuo complex, upregulation of type II NADH dehydrogenase (Ndh), and global induction of translation machinery. These transcriptional changes, together with pre-existing membrane damage, additively enhanced the activity of amikacin against intrinsically resistant N. wallacei (FICI, 0.51-0.56). Conclusions: These findings demonstrate that DHA displays rapid membrane-disruptive activity and can enhance amikacin activity against Nocardia under the defined in vitro conditions.

1 July 2026 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
YPYaqin Peng
Yaqin Peng
JQJiamin Qin
Jiamin Qin
LBLu Bai
Lu Bai
LBLihong Bai
Lihong Bai
XJXiaowen Jiang
Xiaowen Jiang
PGPenghao Guo
Penghao Guo
Background: With the rise of anaerobic bacteremia and resistance to anaerobes for commonly used agents, the resistance patterns of many anaerobes have changed significantly among different geographic areas and medical facilities. This study investigated the clinical and epidemiologic characteristics of anaerobic bacteremia for therapeutic optimization at the local level. Methods: This retrospective observational study included all positive blood cultures (BC) from 2020 to 2024. For patients with anaerobic bacteria originating from BCs, clinical and microbiological data were collected. Results: In total, 239 anaerobic strains were isolated from 223 patients. Among BC-positive bacteria, the proportion of anaerobes accounted for 4.4% (239/5450), with a gradual increase from 3.0% in 2020 to 6.1% in 2024. The most common anaerobes were Bacteroides fragilis (34.7%) and Cutibacterium acnes (20.5%). The resistance rates of gram-negative anaerobes to penicillin, imipenem, and meropenem were 94.4%, 21.1%, and 35.2%, respectively, which were much higher than those of gram-positive anaerobes (16.7%, 0%, 0%). Among the 223 cases, abdominal disorders were the most frequent underlying condition (54.7%). In the empirical antibiotic therapy, 94.6% of the patients received β-lactam antibiotics, and the infection symptoms improved in 74.9% of the patients. For Bacteroides spp. bacteremia, the improvement rate in patients treated with carbapenems and β-lactam/β-lactamase inhibitor combinations was 78.1% and 40.0%, respectively. Conclusion: The study presents valuable data for monitoring and improving anaerobic bacteremia treatment in Southern of China.